KYMPRAME

Welcome to the Brand page for “KYMPRAME”, which is offered here for Pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of tumorous diseases; pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of cancer; pharmaceutical preparations, biological preparations and bispecific reagents for the treatment of melanoma, lung cancer, ovarian cancer, uterine cancer, breast cancer, neurothelial cancer, endometrial cancer, oesophageal cancer, sarcoma, haematological cancers, acute myeloid leukemia, chronic myeloid leukemia, hodgkin's lymphoma, and head and neck cancers;.

Its status is currently believed to be active. Its class is unavailable. “KYMPRAME” is believed to be currently owned by “Immunocore Limited”.